Cargando…

Circulating Cell Free DNA and DNA Integrity Index as Discriminating Tools between Breast Cancer and Benign Breast Disease

OBJECTIVES: Early diagnosis of cancer remains a great challenge in the field of laboratory medicine. We investigated the ability of ccf DNA and DNA integrity index (DNA II) in differentiating benign from malignant breast diseases. METHODS: Serum samples were collected from 50 patients with benign br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elhelaly, Rania, Effat, Narmen, Abd El-Fattah Hegazy, Mohamed, Abdelwahab, Khaled, Hamdy, Omar, Abo Hashem, Ekbal M, Elzehery, Rasha R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272613/ https://www.ncbi.nlm.nih.gov/pubmed/35225467 http://dx.doi.org/10.31557/APJCP.2022.23.2.545

Ejemplares similares

Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females
por: Mashaly, Mervat, et al.
Publicado: (2022)

Thyroid gland dysfunction and vitamin D receptor gene polymorphism in keratoconus
por: Awad, Eman A., et al.
Publicado: (2022)

Breast fibromatosis, an unusual breast disease
por: Abdelwahab, Khaled, et al.
Publicado: (2017)

Ascitic Fluid Calprotectin and Serum Procalcitonin as Accurate Diagnostic Markers for Spontaneous Bacterial Peritonitis
por: Abdel-Razik, Ahmed, et al.
Publicado: (2016)

Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-Related Cirrhosis
por: Abdel-Razik, Ahmed, et al.
Publicado: (2020)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
por: Abdel-Razik, Ahmed, et al.
Publicado: (2020)

Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine
por: Guo, Cheng, et al.
Publicado: (2017)

De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?
por: Abdel-Razik, Ahmed, et al.
Publicado: (2021)

Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast
por: Dong, Fei, et al.
Publicado: (2014)

Discrimination of breast cancer from benign tumours using Raman spectroscopy
por: Lyng, Fiona M., et al.
Publicado: (2019)

Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination
por: Van der Auwera, Ilse, et al.
Publicado: (2010)

Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy
por: Lyng, Fiona M., et al.
Publicado: (2019)

Circulating and local nuclear expression of survivin and fibulin-3 genes in discriminating benign from malignant respiratory diseases: correlation analysis
por: Hassan, Mohammed H., et al.
Publicado: (2021)

De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study
por: Abdel-Razik, Ahmed, et al.
Publicado: (2021)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
por: Vose, B. M., et al.
Publicado: (1979)

Bioimpedance spectroscopy can precisely discriminate human breast carcinoma from benign tumors
por: Du, Zhenggui, et al.
Publicado: (2017)

Mutational pattern of PIK3CA exon 20 in circulating DNA in breast cancer
por: Ibrahim, Iman Hassan, et al.
Publicado: (2022)

High Seroprevalence of Hepatitis C Virus Antibody in Breast Cancer Patients in Egypt
por: Hussein, Osama, et al.
Publicado: (2021)

Benign pneumoperitoneum in newborns: which abdomen to open and which one to observe?
por: Al‐lawama, Manar, et al.
Publicado: (2016)

Value of shear wave elastography in discriminating malignant and benign breast lesions: A meta-analysis
por: Xue, Yan, et al.
Publicado: (2017)

Diffusion-Weighted Imaging for the Discrimination of Benign and Malignant Breast Masses; Utility of ADC and Relative ADC
por: Yılmaz, Ebru, et al.
Publicado: (2018)

Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study
por: Li, Kurt, et al.
Publicado: (2020)

Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination
por: Liu, Jinrui, et al.
Publicado: (2023)

Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Effect of human, bovine and ovine prolactin on DNA synthesis by organ cultures of benign human breast tumours.
por: Welsch, C. W., et al.
Publicado: (1979)

Benign breast myoepithelioma
por: Khan, L, et al.
Publicado: (2013)

Benign Papilloma of the Breast
por: Sadofsky, Moshe
Publicado: (2017)

A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions
por: Franzén, Bo, et al.
Publicado: (2018)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Association of Alanine-Valine Manganese Superoxide Dismutase Gene Polymorphism and Microheterogeneity Manganese Superoxide Dismutase Activity in Breast Cancer and Benign Breast Tissue
por: Atoum, Manar, et al.
Publicado: (2012)

Discrimination of benign from malignant breast lesions in dense breasts with model-based analysis of regions-of-interest using directional diffusion-weighted images
por: Penn, Alan I., et al.
Publicado: (2020)

Validation of the Arabic linguistic version of the Danish Prostatic Symptom Score for benign prostatic hyperplasia associated with lower urinary tract symptoms
por: Hashem, Abdelwahab, et al.
Publicado: (2021)

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
por: Salta, Sofia, et al.
Publicado: (2018)

Diagnostic value of multiple b-value diffusion-weighted imaging in discriminating the malignant from benign breast lesions
por: Lin, Chu-Xin, et al.
Publicado: (2023)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

Genomic profile of advanced breast cancer in circulating tumour DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
por: Shoukry, Mira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1892lhiofp5k80hu418es9u429